IMMUNOGLOBULIN G - ANVISA Registration 80146501278

Access comprehensive regulatory information for IMMUNOGLOBULIN G in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501278 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHADIA AB, THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501278
Registration Details
ANVISA Registration Number: 80146501278
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ABBOTT CLINICAL CHEMISTRY IMMUNOGLOBULIN G - IMUNOGLOBULINA G (IgG) ABBOTT QUIMICA
Risk Class II

Registration Details

80146501278

25351260805200574

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

Aug 22, 2005

VIGENTE

09/18/2025 19:00:01